Shire PLC (SHPG)

181.29
4.15 2.24
NASDAQ : Health Care
Prev Close 185.44
Open 182.61
Day Low/High 180.31 / 183.86
52 Wk Low/High 147.60 / 270.63
Volume 868.93K
Avg Volume 1.07M
Exchange NASDAQ
Shares Outstanding 301.57M
Market Cap 55.92B
EPS 1.30
P/E Ratio 50.39
Div & Yield 0.28 (0.10%)

Latest News

Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth

Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth

Shire posted full-year profits that were largely in-line with analysts' forecasts and said it could see double-digit percentage growth in 2017 earnings per share.

Biotech Buoyed by Deal Talk

Biotech Buoyed by Deal Talk

M&A activity is in a serious upswing, and here are some names to watch.

New Data From Shire Aim To Help Close The Diagnosis And Treatment Gap For People With Hemophilia

New Data From Shire Aim To Help Close The Diagnosis And Treatment Gap For People With Hemophilia

Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care

5 Toxic Stocks to Avoid

5 Toxic Stocks to Avoid

Here's a look at five 'toxic stocks' to sell.

Why Shire, Great Plains, GE Are Waving Red Flags

Why Shire, Great Plains, GE Are Waving Red Flags

The charts of these and two other big stocks are flashing warning signs at investors.

Drug Stocks Find Trump Animus a Bitter Pill

Drug Stocks Find Trump Animus a Bitter Pill

The president-elect's words rattled the sector, though Amgen appears to be shrugging off his remarks.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures and shares in London and Asia fall Thursday after Donald Trump offers few details on his policies during his first press conference since winning the U.S. election.

European Pharma Shares Hammered After Trump Press Conference Attack

European Pharma Shares Hammered After Trump Press Conference Attack

European health care and pharmaceutical company shares were hit hard Thursday after President-elect Donald Trump accused some firms of 'getting away with murder' in his Wednesday press conference.

Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents

Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents

U.S. Patent Office allows Mylan to go after half a dozen patents tied to Allergan's dry eye franchise Restasis.

Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan

Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan

The U.S. Food and Drug Administration turned down Amicus' request to seek accelerated approval for Galafold based on an existing kidney biomarker data.

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

The Swiss biotech was last year reported to be a target of Shire.

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Company to expand into 500 Kendall Street and create a 550,000-square-foot campus focused on rare diseases and highly specialized conditions

Six Thoughts on President Trump and the Durability of the Biotech Stock Rally

Six Thoughts on President Trump and the Durability of the Biotech Stock Rally

Investors have convinced themselves that President Donald Trump is going to make drug stocks great again. Will it last?

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Stock futures are tumbling Wednesday but are well off their lows as Republican Donald Trump is elected the next president of the United States in a surprising victory.

European Drug Companies Get an Injection From Trump Victory

European Drug Companies Get an Injection From Trump Victory

The threat of a government clampdown on drug prices is off the table with Clinton's defeat, while wider support for defensive stocks helped push pharmaceuticals higher.

Stocks Slip in Uncertain Start to November Amid Election Uncertainty

Stocks Slip in Uncertain Start to November Amid Election Uncertainty

Stocks slip on Tuesday in a weaker start to November as uncertainty over the upcoming presidential election weighs on Wall Street.